by Omar Figueroa & Lauren Mendelsohn January 14, 2025 Late in the afternoon on Monday, January 13, 2025, Chief Administrative Law Judge John Mulrooney cancelled the hearing on the merits scheduled for January 21, 2025. Additionally, proceedings in the matter of the proposed rescheduling of marijuana from Schedule I […]
Read More
By Lauren Mendelsohn December 29, 2024 Earlier this month, the U.S. Food and Drug Administration (FDA) issued a warning letter stating that Amanita Mushrooms, its extracts, and certain constituents (muscimol, ibotenic acid, and muscarine) are unapproved food additives, and using them in food products violates the federal Food, Drug […]
Read More
by Omar Figueroa and Lauren Mendelsohn December 27, 2024 On December 23, 2024, a panel of the Fifth Circuit Court of Appeals lifted the lower court injunction which had put enforcement of the Corporate Transparency Act on hold. We previously wrote about the injunction and FinCEN’s response in our […]
Read More
by Omar Figueroa and Lauren Mendelsohn December 23, 2024 On December 23, 2024, a panel of the Fifth Circuit Court of Appeals lifted the lower court injunction which had put enforcement of the Corporate Transparency Act on hold. We previously wrote about the injunction and FinCEN’s response in our […]
Read More
by Omar Figueroa and Lauren Mendelsohn December 10, 2024 On December 3, 2024, a federal court in Texas issued a nationwide preliminary injunction suspending the reporting obligations of the Corporate Transparency Act. The opinion in Texas Top Cop Shop v. Garland can be read below and downloaded here. On […]
Read More
by Omar Figueroa and Lauren Mendelsohn December 6, 2024 On December 3, 2024, a federal court in Texas issued a nationwide temporary injunction suspending the reporting obligations of the Corporate Transparency Act. The opinion in Texas Top Cop Shop v. Garland can be read below and downloaded here. This […]
Read More
by Omar Figueroa & Lauren Mendelsohn December 2, 2024 UPDATE: On, December 3, 2024, a federal court issued a nationwide temporary injunction forbidding enforcement of the Corporate Transparency Act, as detailed in our subsequent blog post which you can read here. In recent years, the U.S. government has […]
Read More
by Omar Figueroa and Lauren Mendelsohn October 29, 2024 On October 29, 2024, the California Court of Appeal for the Second Appellate District, Division 6 issued an astonishing opinion that could have widespread ramifications for the cannabis industry. The appellate decision starts as follows: Many Californians have high expectations that […]
Read More
By Lauren Mendelsohn and Omar Figueroa May 21, 2024 Today, the United States Department of Justice (DOJ) and the Drug Enforcement Administration (DEA) officially posted the Notice of Proposed Rulemaking (NPRM) of the intent to reclassify cannabis from Schedule I to Schedule III of the Controlled Substances Act (CSA). […]
Read More
by Omar Figueroa and Lauren Mendelsohn May 16, 2024 On May 16, 2024, the Biden Administration announced that the United States Department of Justice is taking the next step in the reclassification of cannabis from a Schedule I controlled substance to a Schedule III controlled substance — which would […]
Read More